Aptevo Therapeutics Inc [NASDAQ: APVO] closed the trading session at $0.96.
The stocks have a year to date performance of -87.95 percent and weekly performance of 40.64 percent. The stock has been moved at -92.73 percent over the last six months. The stock has performed -75.88 percent around the most recent 30 days and changed -86.58 percent over the most recent 3-months.
If compared to the average trading volume of 289.34K shares, APVO reached to a volume of 5796365 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about Aptevo Therapeutics Inc [APVO]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for APVO shares is $15.25 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on APVO stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Ladenburg Thalmann have made an estimate for Aptevo Therapeutics Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on November 05, 2018. While these analysts kept the previous recommendation, Piper Jaffray raised their target price to Overweight. The new note on the price target was released on October 05, 2017, representing the official price target for Aptevo Therapeutics Inc stock.
The Average True Range (ATR) for Aptevo Therapeutics Inc is set at 0.36 The Price to Book ratio for the last quarter was 0.03, with the Price to Cash per share for the same quarter was set at 10.50.
APVO stock trade performance evaluation
Aptevo Therapeutics Inc [APVO] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 40.64. With this latest performance, APVO shares dropped by -75.88% in over the last four-week period, additionally sinking by -92.73% over the last 6 months – not to mention a drop of -98.79% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for APVO stock in for the last two-week period is set at 30.13, with the RSI for the last a single of trading hit 35.02, and the three-weeks RSI is set at 30.39 for Aptevo Therapeutics Inc [APVO]. The present Moving Average for the last 50 days of trading for this stock 3.7550, while it was recorded at 0.7613 for the last single week of trading, and 11.7794 for the last 200 days.
Aptevo Therapeutics Inc [APVO]: An insightful look at the core fundamentals
Aptevo Therapeutics Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 2.64 and a Current Ratio set at 2.64.
Aptevo Therapeutics Inc [APVO]: Institutional Ownership
The top three institutional holders of APVO stocks are: VANGUARD GROUP INC with ownership of 1.32 billion shares, which is approximately 8.4983%. BLACKROCK INC., holding 1.04 billion shares of the stock with an approximate value of $200.69 billion in APVO stocks shares; and BERKSHIRE HATHAWAY INC, currently with $174.35 billion in APVO stock with ownership which is approximately 5.8386%.
